Change in Feeding and Swallowing Function in Elderly Patients with Isolated Hospitalization for COVID-19: A Retrospective Cohort Study

被引:0
|
作者
Hamazaki, Kenya [1 ,2 ]
Morikawa, Toru [2 ,3 ]
Nezu, Mari [2 ]
Oh, Koji [1 ]
Nishio, Chihiro [1 ]
Morimoto, Takeshi [2 ]
机构
[1] Kobe City Med Ctr West Hosp, Dept Gen Internal Med, Kobe, Japan
[2] Hyogo Med Univ, Dept Data Sci, Nishinomiya, Hyogo, Japan
[3] Nara City Hosp, Dept Gen Med, Nara, Japan
关键词
Coronavirus disease 2019; COVID-19; Severe acute respiratory syndrome coronavirus 2; Functional oral intake scale; Dysphagia; FRAILTY; DYSPHAGIA; STROKE;
D O I
10.1007/s11606-025-09480-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Isolation was implemented for elderly patients with coronavirus disease 2019 (COVID-19), which interrupted care including oral intake support. ObjectiveTo assess the changes in feeding and swallowing function measured by the functional oral intake scale (FOIS) and their association with post-discharge mortality in elderly COVID-19 patients. Design Single-center retrospective cohort study. Participants We included patients aged >= 65 years and admitted for COVID-19 between December 1, 2021 and March 31, 2023. Those with FOIS before onset (pre-FOIS) 1-3 were excluded. Main Measures We measured FOIS (1-7, 1: no oral intake, 7: normal) before onset and at discharge, and assessed mortality for 180 days after onset. The primary outcome was decrease in FOIS during hospitalization; in-hospital mortality was assumed as 4-level decreases in FOIS. The secondary outcome was 180-day mortality. Association of each pre-FOIS (6, 5, 4) relative to pre-FOIS 7 with the primary outcome was estimated as adjusted common odds ratios (ORs) and 95% confidence intervals (CIs). Association of decreases in FOIS with 180-day mortality was assessed with Kaplan-Meier curve. Key Results We included 337 patients whose median age was 81 years, and 56% of them were men. The distribution of pre-FOIS was 7 (190 patients), 6 (89), 5 (40), and 4 (18). The severity of COVID-19 was generally similar among pre-FOIS levels. The pre-FOIS was significantly associated with decreases in FOIS: adjusted common OR 2.23 [95%CI 1.27-3.92] for pre-FOIS 6, 2.96 [1.46-6.05] for pre-FOIS 5, 2.89 [1.14-7.40] for pre-FOIS 4. The degree of decrease in FOIS was significantly associated with 180-day mortality: no decrease, 4.7%; 1-level decrease, 1.2%; 2-level decrease, 27.9%; 3-level decrease, 46.0%. Conclusions Lower pre-FOIS was associated with further decreases in FOIS in elderly patients who were isolated due to COVID-19, and the degree of decrease was further associated with post-discharge mortality.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study
    Abdulah, Deldar Morad
    Mirza, Abbas Muhammed Sadiq
    MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (01)
  • [42] Otolaryngology consultations for COVID-19 patients: A retrospective cohort study of indications, interventions, and
    Shetty, Kunal R.
    Anderson, Brady J.
    Ahmad, Jumah G.
    Liu, Lucy X.
    Chow, Kevin
    Erickson, Samuel G.
    Shetty, Shohan
    Luong, Amber U.
    AURIS NASUS LARYNX, 2023, 50 (02) : 292 - 298
  • [43] Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study
    Sener, Melahat Uzel
    Yildiz, Murat
    Kavurgaci, Suna
    Ergur, Figen Ozturk
    Sener, Alp
    Ozturk, Ayperi
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2021, 69 (02): : 196 - 206
  • [44] COVID-19 in pediatric palliative care patients: Multicenter, retrospective cohort study
    Korzeniewska-Eksterowicz, Aleksandra
    Brzezinska, Olga
    Dryja, Urszula
    Matczak, Dominka
    Sopilnyak, Andriy
    Szuszkiewicz, Eugenia
    Przyslo, Lukasz
    Szmyd, Krzystof
    Jablonska, Katarzyna
    Krych, Piotr
    Wojtkow-Zielinska, Agnieszka
    Wasinska, Edyta
    Niedzwiecki, Maciej
    PALLIATIVE MEDICINE, 2024, 38 (01) : 150 - 155
  • [45] Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study
    Chilimuri, Sridhar
    Sun, Haozhe
    Alemam, Ahmed
    Kang, Kyoung-Sil
    Lao, Peter
    Mantri, Nikhitha
    Schiller, Lawrence
    Sharabun, Myroslava
    Shehi, Elona
    Tejada, Jairo
    Yugay, Alla
    Nayudu, Suresh Kumar
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 440 - 446
  • [46] Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study
    Weeks, Lachelle D.
    Sylvester, Katelyn W.
    Connors, Jean M.
    Connell, Nathan T.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (04)
  • [47] Short-Stay Hospitalizations for Patients with COVID-19: A Retrospective Cohort Study
    Kilaru, Austin S.
    Lee, Kathleen
    Grossman, Lindsay
    Mankoff, Zachary
    Snider, Christopher K.
    Bressman, Eric
    Porges, Stefanie B.
    Hemmert, Keith C.
    Greysen, Scott R.
    Asch, David A.
    Delgado, Mucio K.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [48] Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study
    Zhe Chen
    Aihua Liu
    Yongjing Cheng
    Xutao Wang
    Xiaomao Xu
    Jia Huang
    Yuqing Ma
    Ming Gao
    Cibo Huang
    BMC Infectious Diseases, 21
  • [49] Predictive Models of Mortality for Hospitalized Patients With COVID-19: Retrospective Cohort Study
    Wang, Taiyao
    Paschalidis, Aris
    Liu, Quanying
    Liu, Yingxia
    Yuan, Ye
    Paschalidis, Ioannis Ch
    JMIR MEDICAL INFORMATICS, 2020, 8 (10)
  • [50] Emergence of Atrial Fibrillation and Flutter in COVID-19 Patients: A Retrospective Cohort Study
    Bhuiya, Tanzim
    Shah, Paras P.
    Lau, Wing Hang
    Park, Timothy
    Munshi, Rezwan F.
    Hai, Ofek
    Zeltser, Roman
    Makaryus, Amgad N.
    HEALTHCARE, 2024, 12 (17)